Senomyx Inc (SNMX) financial statements (2021 and earlier)

Company profile

Business Address 4767 NEXUS CENTRE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:161223273037
Cash and cash equivalents64541115
Short-term investments10918231921
Other undisclosed cash, cash equivalents, and short-term investments00    
Receivables753223
Inventory, net of allowances, customer advances and progress billings2222
Inventory2222  
Prepaid expense and other current assets1
Other current assets01111
Other undisclosed current assets(0)(0)    
Total current assets:252129323340
Noncurrent Assets
Property, plant and equipment333468
Long-term investments and receivables   235
Long-term investments   235
Total noncurrent assets:3336813
TOTAL ASSETS:282433384253
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:555677
Accounts payable110110
Accrued liabilities1112  
Employee-related liabilities334355
Other undisclosed accounts payable and accrued liabilities    11
Deferred revenue and credits0045911
Other undisclosed current liabilities000111
Total current liabilities:5610121818
Noncurrent Liabilities
Liabilities, other than long-term debt222126
Deferred revenue and credits222126
Total noncurrent liabilities:222126
Total liabilities:8811132024
Stockholders' equity
Stockholders' equity attributable to parent191520242026
Common stock000000
Additional paid in capital298293287278262256
Accumulated other comprehensive income (loss)(0)(0)(0)(0)00
Accumulated deficit(280)(278)(267)(255)(243)(231)
Total stockholders' equity:191520242026
Other undisclosed liabilities and equity112123
TOTAL LIABILITIES AND EQUITY:282433384253

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenue, net2297654
Gross profit:292325282931
Operating expenses(31)(34)(38)(40)(41)(41)
Operating loss:(1)(11)(13)(12)(12)(9)
Nonoperating income000000
Net loss available to common stockholders, diluted:(1)(11)(13)(12)(12)(9)

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(1)(11)(13)(12)(12)(9)
Comprehensive loss:(1)(11)(13)(12)(12)(9)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)(0) (0)
Comprehensive loss, net of tax, attributable to parent:(1)(11)(13)(12)(12)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: